首页> 外文会议>MEDINFO >Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients
【24h】

Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients

机译:基于组的术语轨迹分析,用于高级患者的华法林治疗

获取原文

摘要

Atrial fibrillation (AF) patients suffer a high risk of ischemic stroke and other thromboembolism (TE). Warfarin is a long-term oral medication and is effective in reducing TE for AF patients. Identifying the trajectory patterns of warfarin use in AF patients and discovering how different trajectories are associated with different TE outcomes are important for understanding long-term use of warfarin. Also, finding the factors affecting future warfarin use and predicting the warfarin use trajectory for new patients can help to efficiently target the specific patient groups and propose relevant interventions for warfarin use. This paper, combining group-based trajectory modeling and predictive modeling, has successfully discovered three patient groups with distinct warfarin use trajectories. Also, results suggest that the warfarin use trajectory has potential association with the TE outcomes. Moreover, results show factors affecting the future trajectory, which have been used to build prediction models for the warfarin use group.
机译:心房颤动(AF)患者患缺血性卒中和其他血栓栓塞(TE)的风险很高。华法林是一种长期口服药物,可有效减少AF患者的TE。鉴定AF患者中的Warfarin的轨迹模式,并发现如何与不同的TE结果相关的不同轨迹对理解Warfarin的长期使用是重要的。此外,寻找影响未来华法林使用和预测新患者的轨迹的因素可以有助于有效地靶向特定患者群体,并提出有关Warfarin使用的相关干预措施。本文结合基于组的轨迹建模和预测建模,已成功发现三个患者组,具有不同的华法林使用轨迹。此外,结果表明,华法林使用轨迹与TE结果具有潜在的关系。此外,结果显示了影响未来轨迹的因素,这些因素已被用于构建华法林使用组的预测模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号